GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (FRA:JSS) » Definitions » Price-to-Tangible-Book

Nxera Pharma Co (FRA:JSS) Price-to-Tangible-Book : (As of May. 05, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Nxera Pharma Co Price-to-Tangible-Book?

As of today (2025-05-05), Nxera Pharma Co's share price is €5.55. Nxera Pharma Co's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was €-0.63. Hence, Nxera Pharma Co's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Nxera Pharma Co's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Nxera Pharma Co's highest Price to Tangible Book Ratio was 9.59. The lowest was 4.67. And the median was 5.49.

FRA:JSS's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.615
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Nxera Pharma Co's share price is €5.55. Nxera Pharma Co's Book Value per Sharefor the quarter that ended in Dec. 2024 was €4.73. Hence, Nxera Pharma Co's P/B Ratio of today is 1.17.


Nxera Pharma Co Price-to-Tangible-Book Historical Data

The historical data trend for Nxera Pharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Price-to-Tangible-Book Chart

Nxera Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.35 4.51 5.09 - -

Nxera Pharma Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nxera Pharma Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Nxera Pharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nxera Pharma Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Price-to-Tangible-Book falls into.


;
;

Nxera Pharma Co Price-to-Tangible-Book Calculation

Nxera Pharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2024 )
=5.55/-0.628
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Nxera Pharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Nxera Pharma Co Business Description

Traded in Other Exchanges
Address
Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines